Viewing Study NCT05475366


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2025-12-26 @ 2:03 PM
Study NCT ID: NCT05475366
Status: RECRUITING
Last Update Posted: 2025-09-08
First Post: 2022-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)
Sponsor: Institut Curie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module